Abscesses in Crohn's disease. Outcome of medical versus surgical treatment

Juan Carlos Garcia, Seth E. Persky, Peter A L Bonis, Mark Topazian

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Goals: To compare the long-term outcome of medical, percutaneous, and surgical treatment of abdominal and pelvic abscesses complicating Crohn's disease. Study: All patients with Crohn's disease and an abdominal abscess treated at one institution during a 10-year period were retrospectively identified. We reviewed hospital and outpatient records and contacted patients for telephone interviews. Outcome measures included abscess recurrence, subsequent surgery for Crohn's disease, and medications used at the time of most recent follow-up. Results: Fifty-one subjects were identified, with a mean follow-up of 3.75 years. Fewer patients developed recurrent abscesses after initial surgical drainage and bowel resection (12%) than patients treated with medical therapy only or percutaneous drainage (56%) (p = 0.016). One half of the patients treated nonoperatively ultimately required surgery, whereas only 12% of those treated with initial surgery required reoperation during the follow-up period (p = 0.010). Most failures of nonoperative therapy occurred within 3 months. Medication use was similar between the treatment groups at the time of most recent follow-up. Conclusions: In this series, surgical management of abscesses in Crohn's disease was more effective than medical treatment or percutaneous drainage for prevention of abscess recurrence. However, nonoperative therapy prevented subsequent surgery in half of the patients and may be a reasonable treatment option for some patients.

Original languageEnglish (US)
Pages (from-to)409-412
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume32
Issue number5
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Crohn Disease
Abscess
Abdominal Abscess
Drainage
Therapeutics
Recurrence
Hospital Records
Reoperation
Outpatients
Outcome Assessment (Health Care)
Interviews

Keywords

  • Abscess
  • Crohn's disease
  • Treatment

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Abscesses in Crohn's disease. Outcome of medical versus surgical treatment. / Garcia, Juan Carlos; Persky, Seth E.; Bonis, Peter A L; Topazian, Mark.

In: Journal of Clinical Gastroenterology, Vol. 32, No. 5, 2001, p. 409-412.

Research output: Contribution to journalArticle

Garcia, Juan Carlos ; Persky, Seth E. ; Bonis, Peter A L ; Topazian, Mark. / Abscesses in Crohn's disease. Outcome of medical versus surgical treatment. In: Journal of Clinical Gastroenterology. 2001 ; Vol. 32, No. 5. pp. 409-412.
@article{9713c649a48147bb8812dff2a9e3443d,
title = "Abscesses in Crohn's disease. Outcome of medical versus surgical treatment",
abstract = "Goals: To compare the long-term outcome of medical, percutaneous, and surgical treatment of abdominal and pelvic abscesses complicating Crohn's disease. Study: All patients with Crohn's disease and an abdominal abscess treated at one institution during a 10-year period were retrospectively identified. We reviewed hospital and outpatient records and contacted patients for telephone interviews. Outcome measures included abscess recurrence, subsequent surgery for Crohn's disease, and medications used at the time of most recent follow-up. Results: Fifty-one subjects were identified, with a mean follow-up of 3.75 years. Fewer patients developed recurrent abscesses after initial surgical drainage and bowel resection (12{\%}) than patients treated with medical therapy only or percutaneous drainage (56{\%}) (p = 0.016). One half of the patients treated nonoperatively ultimately required surgery, whereas only 12{\%} of those treated with initial surgery required reoperation during the follow-up period (p = 0.010). Most failures of nonoperative therapy occurred within 3 months. Medication use was similar between the treatment groups at the time of most recent follow-up. Conclusions: In this series, surgical management of abscesses in Crohn's disease was more effective than medical treatment or percutaneous drainage for prevention of abscess recurrence. However, nonoperative therapy prevented subsequent surgery in half of the patients and may be a reasonable treatment option for some patients.",
keywords = "Abscess, Crohn's disease, Treatment",
author = "Garcia, {Juan Carlos} and Persky, {Seth E.} and Bonis, {Peter A L} and Mark Topazian",
year = "2001",
doi = "10.1097/00004836-200105000-00010",
language = "English (US)",
volume = "32",
pages = "409--412",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Abscesses in Crohn's disease. Outcome of medical versus surgical treatment

AU - Garcia, Juan Carlos

AU - Persky, Seth E.

AU - Bonis, Peter A L

AU - Topazian, Mark

PY - 2001

Y1 - 2001

N2 - Goals: To compare the long-term outcome of medical, percutaneous, and surgical treatment of abdominal and pelvic abscesses complicating Crohn's disease. Study: All patients with Crohn's disease and an abdominal abscess treated at one institution during a 10-year period were retrospectively identified. We reviewed hospital and outpatient records and contacted patients for telephone interviews. Outcome measures included abscess recurrence, subsequent surgery for Crohn's disease, and medications used at the time of most recent follow-up. Results: Fifty-one subjects were identified, with a mean follow-up of 3.75 years. Fewer patients developed recurrent abscesses after initial surgical drainage and bowel resection (12%) than patients treated with medical therapy only or percutaneous drainage (56%) (p = 0.016). One half of the patients treated nonoperatively ultimately required surgery, whereas only 12% of those treated with initial surgery required reoperation during the follow-up period (p = 0.010). Most failures of nonoperative therapy occurred within 3 months. Medication use was similar between the treatment groups at the time of most recent follow-up. Conclusions: In this series, surgical management of abscesses in Crohn's disease was more effective than medical treatment or percutaneous drainage for prevention of abscess recurrence. However, nonoperative therapy prevented subsequent surgery in half of the patients and may be a reasonable treatment option for some patients.

AB - Goals: To compare the long-term outcome of medical, percutaneous, and surgical treatment of abdominal and pelvic abscesses complicating Crohn's disease. Study: All patients with Crohn's disease and an abdominal abscess treated at one institution during a 10-year period were retrospectively identified. We reviewed hospital and outpatient records and contacted patients for telephone interviews. Outcome measures included abscess recurrence, subsequent surgery for Crohn's disease, and medications used at the time of most recent follow-up. Results: Fifty-one subjects were identified, with a mean follow-up of 3.75 years. Fewer patients developed recurrent abscesses after initial surgical drainage and bowel resection (12%) than patients treated with medical therapy only or percutaneous drainage (56%) (p = 0.016). One half of the patients treated nonoperatively ultimately required surgery, whereas only 12% of those treated with initial surgery required reoperation during the follow-up period (p = 0.010). Most failures of nonoperative therapy occurred within 3 months. Medication use was similar between the treatment groups at the time of most recent follow-up. Conclusions: In this series, surgical management of abscesses in Crohn's disease was more effective than medical treatment or percutaneous drainage for prevention of abscess recurrence. However, nonoperative therapy prevented subsequent surgery in half of the patients and may be a reasonable treatment option for some patients.

KW - Abscess

KW - Crohn's disease

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0035035559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035035559&partnerID=8YFLogxK

U2 - 10.1097/00004836-200105000-00010

DO - 10.1097/00004836-200105000-00010

M3 - Article

VL - 32

SP - 409

EP - 412

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 5

ER -